Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STRADA: Early Switch vs Intensification in Spondyloarthritis
NCT01971918Phase 4Terminated
- Sponsor
- Rouen University Hospital
- Start
- May 2014
- Primary completion
- Apr 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab, adalimumab in spondyloarthritis (SpA), sponsored by Rouen University Hospital. Started May 2014; status: terminated.
02
Drugs
infliximabadalimumab
03
Conditions
spondyloarthritis (SpA)
Beyond the preview
Go deeper on NCT01971918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971918.